» Articles » PMID: 16534872

Autoimmune Thrombocytopenia in Response to Splenectomy in Cirrhotic Patients with Accompanying Hepatitis C

Overview
Specialty Gastroenterology
Date 2006 Mar 15
PMID 16534872
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To estimate the contribution of autoimmune thrombocytopenia to hepatitis C virus-related liver cirrhosis (type C cirrhosis), we evaluated the influence of splenectomy upon platelet-associated immunoglobulin G (PAIgG) levels and platelet numbers.

Methods: PAIgG titers and immune markers were determined in 24 type C cirrhotic patients with an intact spleen, 17 type C cirrhotic patients submitted to splenectomy, and 21 non-C cirrhosis with an intact spleen.

Results: Thrombocytopenia (PLT < 15 x 10(4)/microL) in type C cirrhosis was diagnosed in all patients with an intact spleen, 8 patients submitted to splenectomy, and in 19 non-C cirrhosis with intact spleen. Elevated titers of PAIgG at more than 25.0 ng/10(7) cells were detected in all cirrhotic patients except for one splenectomized patient. PAIgG titers (ng/10(7) cells) were significantly higher in the type C cirrhosis with an intact spleen (247.9+/-197.0) compared with the splenectomized patients (125.6+/-87.8) or non-C cirrhosis (152.4+/-127.4). PAIgG titers were negatively correlated with platelet counts in type C cirrhotic patients with an intact spleen. In comparison with the type C cirrhosis with an intact spleen, the splenectomized patients had a reduced CD4/CD8 ratio and serum neopterin levels. The spleen index (cm2) was negatively correlated with platelet counts in the non-C cirrhosis, but not in the type C cirrhosis.

Conclusion: Our data indicate that the autoimmune mechanism plays an important role in thrombocytosis complicated by HCV-positive cirrhosis. In addition, splenectomy may impair T cells function through, at least in part, a reduction of CD4/CD8 ratio, consequently suppressing PAIgG production.

Citing Articles

Pathogenesis of Thrombocytopenia in Chronic HCV Infection: A Review.

Rawi S, Wu G J Clin Transl Hepatol. 2020; 8(2):184-191.

PMID: 32832399 PMC: 7438357. DOI: 10.14218/JCTH.2020.00007.

References
1.
Samuel H, Nardi M, Karpatkin M, Hart D, Belmont M, Karpatkin S . Differentiation of autoimmune thrombocytopenia from thrombocytopenia associated with immune complex disease: systemic lupus erythematosus, hepatitis-cirrhosis, and HIV-1 infection by platelet and serum immunological measurements. Br J Haematol. 1999; 105(4):1086-91. DOI: 10.1046/j.1365-2141.1999.01469.x. View

2.
Aref S, Mabed M, Selim T, Goda T, Khafagy N . Thrombopoietin (TPO) levels in hepatic patients with thrombocytopenia. Hematology. 2005; 9(5-6):351-6. DOI: 10.1080/10245330400010620. View

3.
Seeff L . Natural history of chronic hepatitis C. Hepatology. 2002; 36(5 Suppl 1):S35-46. DOI: 10.1053/jhep.2002.36806. View

4.
Sanjo A, Satoi J, Ohnishi A, Maruno J, Fukata M, Suzuki N . Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocytopenia of chronic liver diseases. J Gastroenterol Hepatol. 2003; 18(6):638-44. DOI: 10.1046/j.1440-1746.2003.03026.x. View

5.
Gregorio G, Choudhuri K, Ma Y, Pensati P, Iorio R, Grant P . Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection. Clin Exp Immunol. 2003; 133(3):404-13. PMC: 1808793. DOI: 10.1046/j.1365-2249.2003.02229.x. View